Whitehawk Therapeutics, Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$2,599,146
4 notices · 732,520 sh
Oct 2025 to Oct 2026
Reported ·
$2,584,564
14 sales · 0 buys
Oct 2025 to Sep 2026
The two figures cover different periods.
None of the 14 reported sales carry the 10b5-1 box. Together they are 1.24% of the shares on issue.
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
2026-04-15Giacobello Scott M., CHIEF FINANCIAL OFFICER$899,999
Form 4, 2026-04-17: sold 218,600 at $4.03 Form 4 ↗
2026-04-09Lennon David James, CHIEF EXECUTIVE OFFICER$14,750
Form 4, 2026-04-10: sold 14,500 at $3.38 Form 4 ↗
2026-04-09BALL BRYAN, See remarks$649,998
Form 4, 2026-04-13: sold 56,596 at $3.55 Form 4 ↗